Salivary N1-Methyl-2-Pyridone-5-Carboxamide, a Biomarker for Uranium Uptake, in Kuwaiti Children Exhibiting Exceptional Weight Gain
- PMID: 31281289
- PMCID: PMC6596350
- DOI: 10.3389/fendo.2019.00382
Salivary N1-Methyl-2-Pyridone-5-Carboxamide, a Biomarker for Uranium Uptake, in Kuwaiti Children Exhibiting Exceptional Weight Gain
Abstract
In a longitudinal study of 6,158 Kuwaiti children, we selected 94 for salivary metabolomic analysis who were neither obese (by waist circumference) nor metabolic syndrome (MetS) positive (<3 diagnostic features). Half (43) remained healthy for 2 years. The other half (51) were selected because they became obese and MetS positive 2 years later. In the half becoming obese, metabolomic analysis revealed that the level of salivary N1-Methyl-2-pyridone-5-carboxamide (2PY) had the highest positive association with obesity (p = 0.0003, AUC = 0.72) of 441 salivary biochemicals detected. 2PY is a recognized uremic toxin. Also, 2PY has been identified as a biomarker for uranium uptake. Considering that a relatively recent military conflict with documented uranium contamination of the area suggests that this weight gain could be a toxicological effect of long-time, low-level uranium ingestion. Comparison of salivary 2PY in samples from the USA and Kuwait found that only Kuwait samples were significantly related to obesity. Also, the geographic distribution of both reported soil radioactivity from 238U and measured salivary 2PY was highest in the area where military activity was highest. The prevalence pattern of adult diabetes in Kuwait suggests that a transient diabetogenic factor has been introduced into the Kuwaiti population. Although we did not measure uranium in our study, the presence of a salivary biomarker for uranium consumption suggests potential toxicity related to obesity in children.
Keywords: 2PY; N1-Methyl-2-pyridone-5-carboxamide; adolescent obesity; kuwaiti children; metabolic syndrome; nicotinate metabolism; uranium toxicity.
Figures



Similar articles
-
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.Toxins (Basel). 2016 Nov 15;8(11):339. doi: 10.3390/toxins8110339. Toxins (Basel). 2016. PMID: 27854278 Free PMC article. Review.
-
Urinary Excretion of N1-Methylnicotinamide and N1-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients.Nutrients. 2020 Jul 10;12(7):2059. doi: 10.3390/nu12072059. Nutrients. 2020. PMID: 32664445 Free PMC article.
-
Urinary Excretion of N1-methyl-2-pyridone-5-carboxamide and N1-methylnicotinamide in Renal Transplant Recipients and Donors.J Clin Med. 2020 Feb 6;9(2):437. doi: 10.3390/jcm9020437. J Clin Med. 2020. PMID: 32041099 Free PMC article.
-
N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?Kidney Int Suppl. 2003 May;(84):S19-21. doi: 10.1046/j.1523-1755.63.s84.36.x. Kidney Int Suppl. 2003. PMID: 12694300 Review.
-
The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.Mol Cell Biochem. 2004 Dec;267(1-2):25-30. doi: 10.1023/b:mcbi.0000049359.66669.29. Mol Cell Biochem. 2004. PMID: 15663182
Cited by
-
Editorial: Diabetes in the Middle East.Front Endocrinol (Lausanne). 2021 Feb 19;12:638653. doi: 10.3389/fendo.2021.638653. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716990 Free PMC article. No abstract available.
-
The Associations between Blood and Urinary Concentrations of Metal Metabolites, Obesity, Hypertension, Type 2 Diabetes, and Dyslipidemia among US Adults: NHANES 1999-2016.J Environ Public Health. 2021 Oct 25;2021:2358060. doi: 10.1155/2021/2358060. eCollection 2021. J Environ Public Health. 2021. PMID: 34733334 Free PMC article.
-
Use of omics analysis for low-dose radiotoxicology and health risk assessment: the case of uranium.Environ Epigenet. 2022 Nov 2;8(1):dvac025. doi: 10.1093/eep/dvac025. eCollection 2022. Environ Epigenet. 2022. PMID: 36518874 Free PMC article. Review.
-
Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in Adolescents.Front Public Health. 2022 Jun 10;10:800373. doi: 10.3389/fpubh.2022.800373. eCollection 2022. Front Public Health. 2022. PMID: 35757631 Free PMC article.
-
Early Metabolomic Markers of Acute Low-Dose Exposure to Uranium in Rats.Metabolites. 2022 May 7;12(5):421. doi: 10.3390/metabo12050421. Metabolites. 2022. PMID: 35629925 Free PMC article.
References
-
- Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. . Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013:a systematic analysis for the Global Burden of Disease Study 2013. Lancet. (2014) 384:766–81. 10.1016/S0140-6736(14)60460-8 - DOI - PMC - PubMed
-
- El-Reshaid K, Al-Owaish R, Diab A. Hypertension in kuwait, the past, present and future. Saudi J Kidney Dis Transpl. (1999) 10:357–64. - PubMed
-
- IDF . Diabetes Atlas. (2011). Available online at: www.idf.org/diabetesatlas (accessed March 19, 2019).
-
- Clarke RH, Danesi PR, Kutkov VA, Winkler BC, Wilkins BT. Radiological conditions in areas of Kuwait with residues of depleted uranium. In: Clarke RH, editor. IOAEA Safety Standards Series. International Atomic Energy Agency: Vienna; (2003). p. 1–73.
LinkOut - more resources
Full Text Sources